Evidence map›Paper›PMID 40458136›Full record

ArticleJDS communications2025

What can't colostrum do? Exploring the effects of supplementing colostrum after the first day of life: A narrative review.

David L Renaud, Michael A Steele

Abstract read
In one paragraph

Article in JDS communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David L RenaudDepartment of Population Medicine, University of Guelph, Guelph, ON, Canada N1G 2W1.
Michael A SteeleDepartment of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this narrative review is to explore the nontraditional uses of colostrum in dairy calves beyond the first and second feeding after birth. Colostrum is well established as a crucial component of early life management in dairy calves, providing essential antibodies for passive immunity. However, recent studies suggest that extending colostrum supplementation beyond the initial feedings, as well as incorporating transition milk, can yield benefits for calf health and development. Research indicates that such supplementation may lead to enhancements in gut development, improved health scores, and reduced incidence of diseases such as diarrhea and respiratory disease. Furthermore, recent findings have highlighted colostrum's potential to aid in the recovery from diarrhea and support calves during the weaning phase. Despite these findings, the exact mechanisms behind these benefits are still unclear, necessitating further research. Additionally, studies with larger sample sizes and varied housing conditions are needed to fully elucidate colostrum's benefits beyond the first day of life.

Identifiers

PMID40458136
PMCPMC12126837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.